CDC Says Over 556,208 Pfizer/BioNTech COVID-19 Shots Administered In Week 1 Of Inoculation Drive

A week after the COVID-19 mass vaccination effort began, the U.S. Centers for Disease Control and Prevention reports that of 2,838,225 doses distributed across the country, over 556,208 doses had been administered by Sunday.
What Happened: The US Food and Drug Administration has approved two vaccine candidates so far.
The first candidate to receive emergency clearance last week was the candidate co-developed by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX). Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine also received the FDA EUA on Friday.
The statistics shared by the CDC for this week's vaccine delivery all relate to the Pfizer / BioNTech COVID-19 vaccine. The FDA said last week that additional doses could be given in vials of Pfizer COVID-19 vaccine bottles, meaning the company's candidate's offering in the US could increase by 40%.
The CDC Advisory Committee on Immunization Practices approved Moderna's candidates during an emergency meeting on Saturday, paving the way for the administration of the coronavirus shot in the United States.
Why is that important? According to the CDC website, health professionals on the front lines of the epidemic and residents of long-term care facilities will be the first to receive the doses as supplies of the Pfizer vaccine are initially limited.
The CDC website lists two other potential candidates from AstraZeneca PLC (NASDAQ: AZN) and Janssen Pharmaceuticals - a Johnson & Johnson (NYSE: JNJ) entity in the third phase of clinical trials on November 24th.
Price Movement: At the end of Friday's trading session, Pfizer shares fell 0.92% to $ 37.68, BioNTech 2.06% to $ 104.24 and Moderna fell 2.62% to $ 140.23.
Related link: Moderna Analysts Discuss Adcom Judgment, Coronavirus Vaccine Distribution, and Marketing
See more from Benzinga
Click here for Benzinga option trades
SoftBank signs up for first SPAC IPO today, trying to raise up to 0 million: Axios
Lockheed Martin buys defense industry supplier Aerojet In B Deal
© 2020 Benzinga does not offer investment advice. All rights reserved.
In this article
Mention your own website in this post for Advertisement

Last News

Ukraine says Putin snubs Russian troop build-up talks, Moscow lashes U.S

Winners and losers from the 2021 NHL trade deadline

Media Bears Responsibility for Reinforcing Asian American Stereotypes (Guest Column)

China Led The Recovery Trade; Now Almost Everyone Is Cautious

For Indians living on the margins, the fear of a lockdown is greater than that of Covid-19

Retired Navy admiral says U.S. looks either 'complicit' or 'ignorant' in Iran nuclear facility blackout